Management of syncope in pediatric patients

Current Treatment Options in Cardiovascular Medicine

Volumn 7, Issue 5, 2005, Pages 391-398

  Batra, Anjan S ^b   Balaji, Seshadri ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMIODARONE; ANESTHETIC AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC GLYCOSIDE; DIGOXIN; DISOPYRAMIDE; DIURETIC AGENT; FLUDROCORTISONE; FLUOXETINE; GASTROINTESTINAL AGENT; METOPROLOL; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PHENYTOIN; PLASMA SUBSTITUTE; PROPRANOLOL; PSEUDOEPHEDRINE; RIFAMPICIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; UNINDEXED DRUG;

ANAMNESIS; ANXIETY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BRADYCARDIA; CHILDHOOD DISEASE; CLINICAL TRIAL; COMA; CONCENTRATION LOSS; CONGESTIVE HEART FAILURE; CONSTIPATION; COST EFFECTIVENESS ANALYSIS; DELIRIUM; DIARRHEA; DISEASE EXACERBATION; DIZZINESS; DREAMING; DROWSINESS; DRUG COST; DRUG DOSE REGIMEN; DRUG POTENTIATION; DYSURIA; ECHOCARDIOGRAPHY; EDEMA; ENDOCRINE DISEASE; EXCITABILITY; EYE DISEASE; FATIGUE; FEVER; FLUID INTAKE; FLUID THERAPY; GLAUCOMA; GROWTH INHIBITION; HALLUCINATION; HEADACHE; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HEART PALPITATION; HOLTER MONITORING; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; HYPOKALEMIC ALKALOSIS; HYPOMANIA; HYPOTENSION; INSOMNIA; INTRAOCULAR HYPERTENSION; IRRITABILITY; LETHARGY; MANIA; NAUSEA; NERVOUSNESS; PARESTHESIA; PATIENT COUNSELING; PATIENT EDUCATION; PHYSICAL EXAMINATION; POLYURIA; PRURITUS; QRS COMPLEX; QT PROLONGATION; RASH; REFLEX; SALT INTAKE; SEDATION; SEIZURE; SIDE EFFECT; SKIN DEFECT; SOMNOLENCE; SUDDEN DEATH; SUICIDAL BEHAVIOR; SYMPTOMATOLOGY; SYNCOPE; TACHYCARDIA; THORAX PAIN; TILTING; TREMOR; UNPLEASANT DREAM; URINARY URGENCY; URINE RETENTION;

EID: 26444532885     PISSN: 10928464     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11936-005-0023-1     Document Type: Article

References (35)

1. Driscoll DJ, Jacobsen SJ, Porter CJ, Wollan PC: Syncope in children and adolescents. J Am Coll Cardiol 1997, 29:1039-1045.
2. Benditt DG, Ferguson DW, Grubb BP, et al.: Tilt table testing for assessing syncope. J Am Coll Cardiol 1996, 28:263-275.
3. Karas B, Grubb BP, Boehm K, Kip K: The postural orthostatic tachycardia syndrome: a potentially treatable cause of chronic fatigue, exercise intolerance, and cognitive impairment in adolescents. Pacing Clin Electrophysiol 2000, 2:344-351.
4. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992, 20:1391-1396.
5. Kasanuki H, Ohnishi S, Ohtuka M, et al.: Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997, 95:2277-2285.
6. Nademee K, Veerakul G, Nimmannit S, et al.: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997, 96:2595-2600.
7. Hess OM, Sigwart U: New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard? J Am Coll Cardiol 2004, 44:2054-2555.
8. Boriani G, Maron BJ, Shen WK, Spirito P: Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient? Circulation 2004, 110:438-442.
9. Younozai AK, Franklin WH, Chan DP, et al.: Oral fluid therapy: a promising treatment for vasodepresser syncope. Arch Pediatr Adolesc Med 1998, 152:165-168.
10. Di Girolamo E, Di Lorin C, Leonzio L, et al.: Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999, 100:1798-1801.
11. Krediet CTP, van Dijk N, Linzer M, et al.: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation 2002, 106:1684-1689.
12. Almquist A, Goldenberg IF, Milstein S, et al.: Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989, 320:346-351.
13. Muller G, Deal BJ, Strasburger JF, Benson DW Jr: Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol 1993, 71:592-595.
14. O'Marcaigh AS, MacLellan-Tobert SG, Porter CJ: Tilt-table testing and oral metoprolol therapy in young patients with unexplained syncope. Pediatrics 1994, 93:278-283.
15. Balaji S, Oslizlok PC, Allen MC, et al.: Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol 1994, 23:779-785.
16. Raviele A, Brignole M, Sutton R, et al.: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation 1999, 99:1452-1457.
17. Brignole M, Menozzi C, Gianfranchi L, et al.: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992, 70:339-342.
18. Madrid AH, Ortega J, Rebollo JG, et al.: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J Am Coll Cardiol 2001, 37:554-559.
19. Ventura R, Maas R, Zeidler D, et al.: A randomized and controlled pilot trial of beta-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin Electrophysiol 2002, 25:816-821.
20. Alegria JR, Gersh BJ, Scott CG, et al.: Comparison of frequency of recurrent syncope after beta-blocker therapy versus conservative management for patients with vasovagal syncope. Am J Cardiol 2003, 92:82-84.
21. Scott WA, Pongiglione G, Bromberg BI, et al.: Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol 1995, 76:400-402.
22. Samniah N Sakaguchi S, Lurie KC, et al.: Efficacy and safety of midodrine hydrochloride in patients with refractory vasovagal syncope. Am J Cardiol 2001, 88:80-83.
23. Ward CR, Gray JC, Gilroy JJ, Kenny RA: Midodrine: a role in the management of neurocardiogenic syncope. Heart 1998, 79:45-49.
24. Perez-Lugones A, Schweikert R, Pavia S, et al.: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J Cardiovasc Electrophysiol 2001, 12:935-938.
25. Di Girolamo E, Di Iorio C, Sabatini P, et al.: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999, 33:1227-1230.
26. Grubb BP, Samoil D, Kosinski D, et al.: Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 1994, 24:490-494.
27. Milstein S, Buetikofer J, Dunnigan A, et al.: Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am J Cardiol 1990, 65:1339-1344.
28. Morillo CA, Leitch JW, Yee R, Klein GJ: A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993, 22:1843-1848.
29. Strieper MJ, Campbell RM: Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol 1993, 22:594-597.
30. Sutton R, Brignole M, Menozzi C, et al.: Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. Circulation 2000, 102:294-299.
31. Ammirati F, Colivicchi F, Santini M: Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial. Circulation 2001, 104:52-57.
32. Connolly SJ, Sheldon R, Thorpe KE, et al.: Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. JAMA 2003, 289:2224-2249.
33. Deal BJ, Strieper M, Scagliotti D, et al.: The medical therapy of cardioinhibitory syncope in pediatric patients. Pacing Clin Electrophysiol 1997, 20:1759-1761.
34. Moss AJ, Zareba W, Hall WJ, et al.: Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000, 101:616-623.
35. Graham TP Jr, Bricker JT, James FW, Strong WB: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 1: congenital heart disease. J Am Coll Cardiol 1994, 24:867-873.